Central Institutional Review Board (CIRB)

Visit Project Website Go back to Experience
Coordinating Center
Emmes U.S.
Project Status
Active
Project Lifespan
09/30/2006
Objective

The NCI Central Institutional Review Board is dedicated to protecting the rights and welfare of participants in cancer clinical trials. Institutions across the country rely on our national experts to ensure that clinical trials are reviewed efficiently and with the highest ethical and quality standards. We play a critical role in helping the National Cancer Institute accelerate scientific discovery and improve cancer prevention, treatment and care.

Population

The CIRB provides review of protocols submitted by these Networks to ensure the safety of all participants in the trial. The current list of supported Networks includes:
• NCI National Clinical Trials Network (NCTN)
• NCI Experimental Therapeutics Clinical Trials Network (ETCTN)
• NCI Community Oncology Research Program (NCORP)
• Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Phase
I
II
III
IV
Observational
Registry
Centers

The CIRB supports more than 1,800 institutions, such as hospitals and universities, conducting clinical studies aimed at preventing and treating cancer.

Services
Project Management
Statistical Leadership and Project Management
Web-based Data Collection and Reporting Systems
Oncology